Cocaine is the second most commonly used illicit drug and the most frequent cause of drug-related deaths in the United States. 1 Approximately million people in the United States have used cocaine at least once, and five million abuse cocaine on a regular basis.
Its use is associated with acute and chronic complications affecting many organ systems, the most common being the cardiovascular system.
Cocaine Pharmacology
Cocaine acts as a powerful sympathomimetic agent. Cocaine has two main mechanisms of action. Its first mechanism involves the inhibition of cellular sodium ion transport through blockade of fast sodium ion channels, resulting in membrane stabilization and a local anesthetic effect. In the myocardium, this effect is similar to that produced by class 1 antiarrhythmic agents.
The second mechanism is a marked increase in catecholamine levels at the synapse by blockage of presynaptic reuptake of epinephrine, norepinephrine, and dopamine. The result is elevated levels of these neurotransmitters at the postsynaptic receptors.
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Stimulation of α-adrenergic receptors leads to coronary vasoconstriction. 6 Cocaine not only causes spasm of the large coronary arteries but is toxic to cardiac muscle. Excessive β-adrenergic stimulation from cocaine causes calcium overload, which directly leads to cardiac myocyte toxicity.
7 Stimulation of β-adrenergic receptors has positive chronotropic and inotropic effects on the myocardium and thus increases myocardial oxygen demand. Due to increased norepinephrine activity on α-and β-adrenergic receptors, cocaine produces a dose-dependent increase in heart rate and blood pressure, which usually remains within physiological levels in recreational use. 8 In human volunteers, intranasal cocaine produces a significant increase in blood pressure, heart rate, coronary vascular resistance, and myocardial oxygen consumption compared to intranasal saline administration. 9 Lastly, cocaine can precipitate coronary thrombosis.
10 It increases platelet aggregation through elevated levels of thromboxane A and epinephrine.
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Cocaine and Chest Pain
Chest pain is the most common symptom reported by cocaine users. 1 Data suggests that most patients with chest pain are not questioned about cocaine use and if they are, the answer is often not documented.
1 Fifty-seven percent of cocaine users complaining of chest pain are admitted to the hospital. 1 Acute coronary events and myocardial infarction can occur within minutes to days after cocaine administration.
15 Cocaineinduced myocardial infarction is difficult to diagnose since the most common ECG finding is early repolarization and left ventricular hypertrophy. 16 The anterior wall is involved in 77% of cases of cocaine-induced myocardial infarction.
17 A small case study found users of cocaine have a transient -fold increase in risk of myocardial infarction in the first hour after use which decreases rapidly thereafter.
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Management of Cocaine-induced Chest Pain
Patients who have myocardial ischemia secondary to cocaine use are medically treated differently from patients who have myocardial ischemia unrelated to cocaine. Current recommendations for the treatment of cocaine-induced myocardial ischemia include use of benzodiazepines, cautious use of thrombolytics, and avoidance of beta-blockers.
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Controversy over β-blocker usage
During myocardial infarctions, β-blockers prevent the excessive catecholamine stimulation that leads to myocardial necrosis or stunning.
0 The benefit of β-blockers in myocardial infarction is the prevention of reinfarction and ventricular fibrillation. As a result of these findings, propranolol became the preferred treatment for cocaine-induced hypertension until 1985 when Ramoska and Sacchetti suggested that propranolol should be used with caution due to its potential for causing paradoxical hypertension via "unopposed alpha stimulation."
By blocking the β-adrenergic receptors, available neurotransmitters predominantly bind α-adrenergic receptors on smooth muscle and cause vasoconstriction of blood vessels, thereby elevating blood pressure.
However, a recent retrospective study of 6 consecutive telemetry and ICU patients who were admitted to a municipal hospital for chest pain and had positive urine toxicology results for cocaine demonstrated a decrease, rather than an increase, in the risk of death and myocardial infarction with β-blocker administration. The incidence of myocardial infarction in the group of patients treated with β-blockers was significantly lower than the group without therapy (6.1% vs. 6%; 95% CI: 10.-0%).
In a corresponding editorial, Freeman and Feldman question the premise that cocaine chest pain is due to coronary artery spasm.
5 Firstly, cardiac catheterization in initial studies of patients with cocaine-induced chest pain was conducted in a delayed fashion, so that spontaneous thrombolysis could not be excluded.
6 Secondly, reversible coronary perfusion defects, consistent with coronary vasospasm, are rarely demonstrated in acute myocardial perfusion imaging.
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In a small clinical study, labetalol was shown to reverse the cocaine-induced rise in mean arterial pressure, but does not alleviate cocaine-induced coronary vasoconstriction.
8 However, to date no clinical trials have been conducted on the initial management of cocaine-associated ischemia or infarction. Specifically, a study to assess the risk-to-benefit ratio of β-blocker usage in patients who complain of chest pain and test positive for cocaine would provide much needed clarification.
